MediPharm Labs Q3 2026: 18% Revenue Rise, Strong Profit & Global ExpansionStrong Q3 2026: MediPharm Labs posts 18% revenue rise, 32% gross margin and expands in Brazil with ANVISA‑approved cannabis oil.MEDIPHARM LABS CORP Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 12/11/2026, 16:37 2 minutes to read